Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Sold by Steward Partners Investment Advisory LLC

Steward Partners Investment Advisory LLC trimmed its holdings in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBEGet Rating) by 75.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 569 shares of the company’s stock after selling 1,785 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Invesco Dynamic Biotechnology & Genome ETF were worth $33,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of PBE. Kestra Advisory Services LLC acquired a new stake in Invesco Dynamic Biotechnology & Genome ETF during the 1st quarter valued at approximately $336,000. Commonwealth Equity Services LLC lifted its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 8.1% in the 1st quarter. Commonwealth Equity Services LLC now owns 9,835 shares of the company’s stock valued at $610,000 after purchasing an additional 738 shares during the period. Western Wealth Management LLC acquired a new position in shares of Invesco Dynamic Biotechnology & Genome ETF in the 1st quarter valued at $272,000. Cetera Advisor Networks LLC lifted its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 23.3% in the 1st quarter. Cetera Advisor Networks LLC now owns 26,604 shares of the company’s stock valued at $1,650,000 after purchasing an additional 5,019 shares during the period. Finally, Atria Wealth Solutions Inc. acquired a new position in shares of Invesco Dynamic Biotechnology & Genome ETF in the 1st quarter valued at $221,000.

Invesco Dynamic Biotechnology & Genome ETF Trading Down 0.2 %

PBE opened at $65.10 on Monday. The firm has a fifty day moving average price of $61.05 and a 200 day moving average price of $59.82. Invesco Dynamic Biotechnology & Genome ETF has a 1 year low of $51.39 and a 1 year high of $73.66.

About Invesco Dynamic Biotechnology & Genome ETF

(Get Rating)

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Featured Stories

Want to see what other hedge funds are holding PBE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBEGet Rating).

Institutional Ownership by Quarter for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)

Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.